Trials / Completed
CompletedNCT05256043
Investigation of Critically Ill Patients With Newly Diagnosed Diabetes
Case-control Investigation of Critically Ill Patients With Newly Diagnosed Diabetes: Clinical Characteristics, Glucose Metrics and Outcomes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,777 (actual)
- Sponsor
- Stamford Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the clinical outcomes and glucose control metrics of critically ill patients with previously undiagnosed diabetes compared to those with known diabetes at the time of admission to the intensive care unit (ICU).
Detailed description
This case control study compares previously undiagnosed diabetic patients (defined as HbA1c \> 6.5% and no history of diabetes), to those with known diabetes, using 1:1 matching. Patients met inclusion criteria by having HbA1c available on ICU admission and at least four blood glucose tests during their ICU stay. Primary outcomes included ICU length of stay and inpatient mortality. Secondary outcomes included glucose metrics: mean blood glucose, coefficient of variation and percentage of patients who developed hypoglycemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Diabetes Diagnosis | HbA1c \> 6.5% |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2019-12-31
- Completion
- 2022-01-01
- First posted
- 2022-02-25
- Last updated
- 2022-02-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05256043. Inclusion in this directory is not an endorsement.